GlyTherix is among 25 biotech companies presenting at the AusBiotech Invest & Partnering Session on Thursday 31 October at Melbourne Convention & Exhibition Centre.

Brad Walsh will provide an update on Miltuximab, the company’s novel treatment for solid tumors. Save the date to meet us at the event!